Title:
放射線治療薬および放射線治療と併用した、活性ビタミンD化合物による癌の治療法
Document Type and Number:
Japanese Patent JP2007501865
Kind Code:
A
Abstract:
The present invention relates to a method for treating cancer in an animal by administering to the animal an active vitamin D compound or a mimic thereof in combination with a radiotherapeutic agent or treatment.
Inventors:
Card John Gee.
Application Number:
JP2006533616A
Publication Date:
February 01, 2007
Filing Date:
June 10, 2004
Export Citation:
Assignee:
Novacea Incorporated
International Classes:
A61K31/59; A61K9/48; A61K31/355; A61K31/593; A61K41/00; A61K45/00; A61K45/06; A61K47/10; A61K51/00; A61P3/14; A61P35/00
Domestic Patent References:
| JP2002509888A | 2002-04-02 | |||
| JP2002509888A | 2002-04-02 |
Other References:
JPN6010065112, ＧＥＷＩＲＴＺ，Ｄ．Ａ． ｅｔ ａｌ, "Ｖｉｔａｍｉｎ Ｄ３ ａｎｄ ｖｉｔａｍｉｎ Ｄ３ ａｎａｌｏｇｕｅｓ ａｓ ａｎ ａｄｊｕｎｃｔ ｔｏ ｃａｎｃｅｒ ｃｈｅｍｏｔｈｅｒａｐｙ ａｎｄ ｒａｄｉｏｔｈｅｒａｐｙ", Ｃｕｒｒｅｎｔ Ｍｅｄｉｃｉｎａｌ Ｃｈｅｍｉｓｔｒｙ： Ａｎｔｉ−Ｃａｎｃｅｒ Ａｇｅｎｔｓ, 2002, Ｖｏｌ．２， Ｎｏ．６, ｐ．６８３−６９０
JPN6010065113, ＧＥＷＩＲＴＺ，Ｄ．Ａ． ｅｔ ａｌ, "Ｅｎｈａｎｃｅｍｅｎｔ ｏｆ ｂｒｅａｓｔ ｔｕｍｏｒ ｃｅｌｌ ｓｅｎｓｉｔｉｖｉｔｙ ｔｏ ｆｒａｃｔｉｏｎａｔｅｄ ｒａｄｉａｔｉｏｎ ａｎｄ ｓｕｓｃｅｐｔｉｂｉｌｉｔｙ ｔｏ ａｐｏｐｔｏｓ", Ｐｒｏｃｅｅｄｉｎｇｓ ｏｆ ｔｈｅ Ａｍｅｒｉｃａｎ Ａｓｓｏｃｉａｔｉｏｎ ｆｏｒ Ｃａｎｃｅｒ Ｒｅｓｅａｒｃｈ Ａｎｎｕａｌ Ｍｅｅｔｉｎｇ, 2001, Ｖｏｌ．４２, ｐ．９３
JPN6010065114, ＳＵＮＤＡＲＡＭ，Ｓ． ｅｔ ａｌ, "Ｔｈｅ ｖｉｔａｍｉｎ Ｄ３ ａｎａｌｏｇ ＥＢ １０８９ ｅｎｈａｎｃｅｓ ｔｈｅ ｒｅｓｐｏｎｓｅ ｏｆ ｈｕｍａｎ ｂｒｅａｓｔｔｕｍｏｒ ｃｅｌｌｓ ｔｏ ｒａｄｉａｔｉｏｎ", Ｒａｄｉａｔｉｏｎ Ｒｅｓｅａｒｃｈ, 1999, Ｖｏｌ．１５２， Ｎｏ．５, ｐ．４７９−４８６
JPN6010065113, ＧＥＷＩＲＴＺ，Ｄ．Ａ． ｅｔ ａｌ, "Ｅｎｈａｎｃｅｍｅｎｔ ｏｆ ｂｒｅａｓｔ ｔｕｍｏｒ ｃｅｌｌ ｓｅｎｓｉｔｉｖｉｔｙ ｔｏ ｆｒａｃｔｉｏｎａｔｅｄ ｒａｄｉａｔｉｏｎ ａｎｄ ｓｕｓｃｅｐｔｉｂｉｌｉｔｙ ｔｏ ａｐｏｐｔｏｓ", Ｐｒｏｃｅｅｄｉｎｇｓ ｏｆ ｔｈｅ Ａｍｅｒｉｃａｎ Ａｓｓｏｃｉａｔｉｏｎ ｆｏｒ Ｃａｎｃｅｒ Ｒｅｓｅａｒｃｈ Ａｎｎｕａｌ Ｍｅｅｔｉｎｇ, 2001, Ｖｏｌ．４２, ｐ．９３
JPN6010065114, ＳＵＮＤＡＲＡＭ，Ｓ． ｅｔ ａｌ, "Ｔｈｅ ｖｉｔａｍｉｎ Ｄ３ ａｎａｌｏｇ ＥＢ １０８９ ｅｎｈａｎｃｅｓ ｔｈｅ ｒｅｓｐｏｎｓｅ ｏｆ ｈｕｍａｎ ｂｒｅａｓｔｔｕｍｏｒ ｃｅｌｌｓ ｔｏ ｒａｄｉａｔｉｏｎ", Ｒａｄｉａｔｉｏｎ Ｒｅｓｅａｒｃｈ, 1999, Ｖｏｌ．１５２， Ｎｏ．５, ｐ．４７９−４８６
Attorney, Agent or Firm:
Hatsushi Shimizu
Koichi Niimi
Koichi Niimi